News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

MannKind Biopharmaceuticals (MNKD) Says in New Partnership Talks on Afrezza



2/2/2010 6:51:25 AM

Bookmark and Share

Reuters -- MannKind Corp said it has opened partnership talks with "a few new parties" on its inhaled insulin product Afrezza and reengaged in talks with a previous candidate. In a conference call with analysts, the company also said it currently has enough cash to fund operations till at least the first quarter of 2011.

Read at Reuters


comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES